The results suggest that this fraction is a source of PTP1B inhibitory activity with a potential for treating diabetes.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: